Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy
Language English Country United States Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
PubMed
31170541
DOI
10.1016/j.jaip.2019.05.042
PII: S2213-2198(19)30499-4
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Gestational Age MeSH
- Angioedemas, Hereditary drug therapy MeSH
- Complement C1 Inhibitor Protein administration & dosage adverse effects therapeutic use MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Recombinant Proteins administration & dosage adverse effects therapeutic use MeSH
- Pregnancy MeSH
- Pregnancy Outcome MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- conestat alfa MeSH Browser
- Complement C1 Inhibitor Protein MeSH
- Recombinant Proteins MeSH
Allergy and Asthma Specialists of Dallas Dallas Texas
MediQuest Clinical Research Sangeorgiu de Mures Romania
Pharming Healthcare Inc Bridgewater NJ
University of Cincinnati College of Medicine Cincinnati Ohio
References provided by Crossref.org
